Yahoo Finance CEO, Interim President & Vice Chairman of the Board of TFF Pharmaceuticals Picks Up 280% More Stock
Potential TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) shareholders may wish to note that the CEO, Interim President & Vice Chairman of the Board, Harlan Weisman, recently bought US$150k worth of stock, paying US$0.25 for each share. That certainly has us anticipating the best, especially since they thusly increased their own holding by 280%, potentially signalling some real optimism.
See our latest analysis for TFF Pharmaceuticals
TFF Pharmaceuticals Insider Transactions Over The Last Year
In fact, the recent purchase by Harlan Weisman was the biggest purchase of TFF Pharmaceuticals shares made by an insider individual in the last twelve months, according to our records. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$0.37. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
In the last twelve months TFF Pharmaceuticals insiders were buying shares, but not selling. Their average price was about US$0.43. This is nice to see since it implies that insiders might see value around current prices. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
TFF Pharmaceuticals is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
Insider Ownership Of TFF Pharmaceuticals
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 9.0% of TFF Pharmaceuticals shares, worth about US$1.9m, according to our data. We do generally prefer see higher levels of insider ownership.
So What Do The TFF Pharmaceuticals Insider Transactions Indicate?
It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. On this analysis the only slight negative we see is the fairly low (overall) insider ownership; their transactions suggest that they are quite positive on TFF Pharmaceuticals stock. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. When we did our research, we found 5 warning signs for TFF Pharmaceuticals (3 are potentially serious!) that we believe deserve your full attention.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
